Linda Van Le

Medicine · Health Sciences

17h-index2.3kcitations64works2.62yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Ovarian cancer diagnosis and treatment(35), PARP inhibition in cancer therapy(12), Endometrial and Cervical Cancer Treatments(8), BRCA gene mutations in cancer(7), Intraperitoneal and Appendiceal Malignancies(7)

Publications64 total

Rucaparib maintenance in ATHENA-MONO (GOG-3020/ENGOT-ov45) in patients with newly diagnosed advanced ovarian cancer: exploratory post-progression evaluations for patients with HRD-negative and HRD-unknown tumours
International Journal of Gynecological Cancer·2026
Feasibility of deep learning-accelerated HASTE-FS for pancreatic cystic lesion surveillance: comparison with conventional HASTE and MRCP
Abdominal Radiology·2025
Factors Associated With Aborted Whipple Procedures for Periampullary Carcinoma: A Multicenter Case-Control Study by the SAR Pancreatic Ductal Adenocarcinoma Disease Focus Panel
American Journal of Roentgenology·2025· 1 cited
ATHENA-MONO Post-Progression Survival Data Update In Patients With Newly Diagnosed Advanced Ovarian Cancer
International Journal of Gynecological Cancer·2025Open Access
Health-related quality of life in patients with newly diagnosed advanced ovarian cancer treated with niraparib vs placebo: Results from the phase 3 randomized PRIMA/ENGOT-OV26/GOG-3012 trial
Gynecologic Oncology·2024· 12 citedOpen Access
Obesity is associated with worse quality of life in women with gynecologic malignancies: An opportunity to improve patient-centered outcomes
UNC Libraries·2023Open Access
O026/#560 Efficacy analysis by disease risk subgroup for the phase 3 athena-mono study (GOG-3020/engot-OV45) evaluating rucaparib maintenance treatment in patients with newly diagnosed ovarian cancer
International Journal of Gynecological Cancer·2022· 3 citedOpen Access
A clinical calculator to personalize chemotherapy in early-stage clear cell ovarian cancer
Gynecologic Oncology·2021
A clinical calculator to personalize chemotherapy in early-stage high risk epithelial ovarian cancer
Gynecologic Oncology·2021
17 Safety and patient-reported outcomes in patients receiving niraparib in the PRIMA/ENGOT-OV26/GOG-3012 trial
2020· 2 citedOpen Access
Patient-reported outcomes (PRO) in patients receiving niraparib in the PRIMA/ENGOT-OV26/GOG-3012 trial
Geburtshilfe und Frauenheilkunde·2020
Use of a clinical score to predict chemotherapy response in stage I mucinous ovarian cancers
Gynecologic Oncology·2020
818P Veliparib with carboplatin and paclitaxel in frontline high-grade serous ovarian cancer (HGSOC): Efficacy and safety of paclitaxel weekly and every 3 weeks in the VELIA study
Annals of Oncology·2020· 3 cited
810MO Patient-reported outcomes (PROs) in patients (pts) receiving niraparib in the PRIMA/ENGOT-OV26/GOG-3012 trial
Annals of Oncology·2020· 7 citedOpen Access
Prevalence and Severity of Anemia in Haiti
American Society for Clinical Laboratory Science·2019Open Access
341 Ovarian cancer care at a hospital with an igcs global curriculum fellowship
2019Open Access
Single-Arm Phases 1 and 2 Trial of Niraparib in Combination With Pembrolizumab in Patients With Recurrent Platinum-Resistant Ovarian Carcinoma
JAMA Oncology·2019· 533 citedOpen Access
Randomized Trial of Intravenous Versus Intraperitoneal Chemotherapy Plus Bevacizumab in Advanced Ovarian Carcinoma: An NRG Oncology/Gynecologic Oncology Group Study
Journal of Clinical Oncology·2019· 229 citedOpen Access
TOPACIO/Keynote-162 (NCT02657889): A phase 1/2 study of niraparib + pembrolizumab in patients (pts) with advanced triple-negative breast cancer or recurrent ovarian cancer (ROC)—Results from ROC cohort.
Journal of Clinical Oncology·2018· 138 cited
Evaluation of a Streamlined Oncologist-Led <i>BRCA</i> Mutation Testing and Counseling Model for Patients With Ovarian Cancer
Journal of Clinical Oncology·2018· 95 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Paola A. Gehrig(11), Wendy R. Brewster(6), Victoria Bae‐Jump(6), Wesley C. Fowler(5), Daniel L. Clarke‐Pearson(5), Noelle Cloven(5), John F. Boggess(4), Parag Kumar(4), Whitney P. Caron(4), William C. Zamboni(4), Bhavana Pothuri(4), Florian Heitz(4), Robert A. Burger(4), Lydia Gaba(4), David Bender(4), Jacob Korach(4), Philippe Follana(4), Carmela Pisano(4), Ulla Peen(4), Johanna Mäenpää(4)